Pfizer earnings and revenue comfortably beat Q3 estimates, with the pharma giant raising full-year guidance. Shares rose Tuesday.

The post Pfizer Earnings Top Q3 Views; Pharma Giant Guides Higher appeared first on Investor’s Business Daily.